ViroLogic Inc. (VLGC) has merged with Aclara Biosciences Inc. (ACLA) in a stock swap valued at $180MM. But William Young, the CEO and Chairman of ViroLogic, will lead the new company, and Aclara will close its Mountain View facilities, moving all operations to ViroLogic’s headquarters in South San Francisco, near Genentech (DNA). So it sounds like to us that another genomics company bites the dust.
